Treatment strategies for child cardiomyopathy(2023 edition):Interpretation of an American Heart Association scientific statement
In 2023,the American Heart Association(AHA)issued a scientific statement on the treatment strategies for child cardiomyopathy,focusing on dilated and hypertrophic cardiomyopathies,which addresses the lack of treatment options for children-specific cardiomyopathies and provides options based on the AHA perspective.The purpose of this paper is to interpret this scientific statement in order to provide an AHA-based decision-making evidence for domestic colleagues to develop treatment programs for children with cardiomyopathies.
国家科技期刊平台
NSTL
万方数据
